Skip to content
  • Friday, 14 August 2026
  • 11:24 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.
Pharmaceutical R&D

AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.

Teuku Ryan Jul 21, 2026 0

Artificial intelligence (AI) is rapidly transforming various sectors, and clinical data management is no exception. While the potential applications of…

Read More
Pharmaceutical R&D

Brinsupri Poised to Redefine Bronchiectasis Treatment Standards Following Robust ATS 2026 Showcase

Teuku Ryan Jun 2, 2026 0

The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…

Read More
Biotech & Genetic Research

Cavidi AB’s BOLD Technology Sets New Standards in Immunoassay Sensitivity and Precision for Biomedical Research and Diagnostics

Jia Lissa May 9, 2026 0

Cavidi AB is making significant strides in enhancing the capabilities of immunoassays, a cornerstone technique in diagnostics and biomedical research,…

Read More
TWiV 1289: Building a better hepatitis B trapThe Proof in the Code Chronicles the Algorithmic Ascent in MathematicsEli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic TherapeuticsPolars Emerges as a High-Performance Challenger to Pandas in Python Data Processing
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ